{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:18Z","timestamp":1791357438635,"version":"4.3.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.smrv.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T12:16:32Z","timestamp":1541679392000},"page":"23-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy"],"prefix":"10.1016","volume":"43","author":[{"given":"Steven T.","family":"Szabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Thorpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Peever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Kilduff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2018.09.006_bib1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.sleep.2014.01.015","article-title":"Delayed diagnosis of narcolepsy: characterization and impact","volume":"15","author":"Thorpy","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib2","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMra1500587","article-title":"Narcolepsy","volume":"373","author":"Scammell","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.sleep.2014.02.001","article-title":"The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings","volume":"15","author":"Black","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2015.12.002","article-title":"Challenges in the development of therapeutics for narcolepsy","volume":"152","author":"Black","year":"2017","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.smrv.2018.09.006_bib5","series-title":"The international classification of sleep disorders \u2013 third edition (ICSD-3)","author":"American Academy of Sleep Medicine","year":"2014"},{"key":"10.1016\/j.smrv.2018.09.006_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5664\/jcsm.6494","article-title":"Listening to the patient voice in narcolepsy: diagnostic delay, disease burden, and treatment efficacy","volume":"13","author":"Maski","year":"2017","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib7","series-title":"Sleep\u2013wake disorders: narcolepsy. Diagnostic and statistical manual of mental disorders fifth edition (DSM-5)","first-page":"372","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.smrv.2018.09.006_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamaneurol.2013.1589","article-title":"Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy\/hypocretin deficiency","volume":"70","author":"Andlauer","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.smrv.2018.09.006_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.sleep.2016.04.004","article-title":"Medical comorbidity in narcolepsy: findings from the Burden of Narcolepsy Disease (BOND) study","volume":"33","author":"Black","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib10","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1212\/WNL.0000000000001051","article-title":"Primary progressive narcolepsy type 1: the other side of the coin","volume":"83","author":"Pizza","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2018.09.006_bib11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.5664\/jcsm.6196","article-title":"Flumazenil for the treatment of refractory hypersomnolence: clinical experience with 153 patients","volume":"12","author":"Trotti","year":"2016","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4088\/JCP.15m10262","article-title":"High rates of psychiatric comorbidity in narcolepsy: findings from the burden of narcolepsy disease (BOND) study of 9,312 patients in the United States","volume":"78","author":"Ruoff","year":"2017","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.smrv.2018.09.006_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jsmc.2017.03.016","article-title":"Depression and hypersomnia: a complex association","volume":"12","author":"Lopez","year":"2017","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.smrv.2018.09.006_bib14","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2018.09.006_bib15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ng.647","article-title":"Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy","volume":"42","author":"Hor","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.smrv.2018.09.006_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5665\/sleep.3300","article-title":"DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe","volume":"37","author":"Tafti","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajhg.2014.12.010","article-title":"HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy","volume":"96","author":"Ollila","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.smrv.2018.09.006_bib18","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/brain\/awx093","article-title":"Rare missense mutations in P2RY11 in narcolepsy with cataplexy","volume":"140","author":"Degn","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2018.09.006_bib19","doi-asserted-by":"crossref","first-page":"16100","DOI":"10.1038\/nrdp.2016.100","article-title":"Narcolepsy","volume":"3","author":"Kornum","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.smrv.2018.09.006_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12026-014-8513-4","article-title":"History of narcolepsy at Stanford University","volume":"58","author":"Mignot","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.smrv.2018.09.006_bib21","article-title":"Anti-tribbles pseudokinase 2 (TRIB2)-immunization modulates hypocretin\/orexin neuronal functions","volume":"40","author":"Tanaka","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib22","doi-asserted-by":"crossref","first-page":"E3735","DOI":"10.1073\/pnas.1412189111","article-title":"Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns","volume":"111","author":"Bergman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smrv.2018.09.006_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbi.2013.12.019","article-title":"Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study","volume":"37","author":"Dauvilliers","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.smrv.2018.09.006_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","article-title":"T\u00a0cells in patients with narcolepsy target self-antigens of hypocretin neurons","volume":"562","author":"Latorre","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.smrv.2018.09.006_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/d41586-018-06666-w","article-title":"Put to sleep by immune cells","volume":"562","author":"Liblau","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.smrv.2018.09.006_bib26","article-title":"Autoimmunity to hypocretin and molecular mimicry to flu antigens in Type 1 narcolepsy","author":"Luo","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.smrv.2018.09.006_bib27","doi-asserted-by":"crossref","first-page":"10956","DOI":"10.1073\/pnas.1603325113","article-title":"CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice","volume":"113","author":"Bernard-Valnet","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smrv.2018.09.006_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tins.2013.01.008","article-title":"Neurons as targets for T cells in the nervous system","volume":"36","author":"Liblau","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.smrv.2018.09.006_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.phrs.2014.10.005","article-title":"Is narcolepsy a classical autoimmune disease?","volume":"92","author":"Arango","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.smrv.2018.09.006_bib30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.smrv.2018.09.006_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2869.2009.00756.x","article-title":"Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people","volume":"19","author":"Koepsell","year":"2010","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.smrv.2018.09.006_bib32","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/sleep\/32.8.979","article-title":"Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset","volume":"32","author":"Aran","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference","volume":"25","author":"Chang","year":"2015","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.smrv.2018.09.006_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009995","article-title":"Retraction of the research article: \u201cCD4(+) T cell autoimmunity to hypocretin\/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy\u201d","volume":"6","author":"De la Herran-Arita","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.23799","article-title":"Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic","volume":"73","author":"Han","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.smrv.2018.09.006_bib36","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1474-4422(14)70168-1","article-title":"Does autoreactivity have a role in narcolepsy?","volume":"13","author":"Partinen","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.smrv.2018.09.006_bib37","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.0000000000000987","article-title":"Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States","volume":"83","author":"Duffy","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2018.09.006_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","article-title":"Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants","volume":"50","author":"Ahmed","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.smrv.2018.09.006_bib39","doi-asserted-by":"crossref","first-page":"e108489","DOI":"10.1371\/journal.pone.0108489","article-title":"Risk of narcolepsy associated with inactivated adjuvanted (AS03) A\/H1N1 (2009) pandemic influenza vaccine in Quebec","volume":"9","author":"Montplaisir","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.smrv.2018.09.006_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/atm.2016.12.63","article-title":"Narcolepsy and influenza vaccination-induced autoimmunity","volume":"5","author":"Ahmed","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib41","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.0b013e3181bd1344","article-title":"Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment","volume":"73","author":"Dauvilliers","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2018.09.006_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/WNL.0b013e31825dce03","article-title":"Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency","volume":"79","author":"Knudsen","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2018.09.006_bib43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrneurol.2014.97","article-title":"Cataplexy--clinical aspects, pathophysiology and management strategy","volume":"10","author":"Dauvilliers","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.smrv.2018.09.006_bib44","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/01.wnl.0000218205.72668.ab","article-title":"Cerebral perfusion changes during cataplexy in narcolepsy patients","volume":"66","author":"Hong","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2018.09.006_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1364-6613(00)01818-0","article-title":"Sleep imaging and the neuro-psychological assessment of dreams","volume":"6","author":"Schwartz","year":"2002","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.smrv.2018.09.006_bib46","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0306-4522(98)00600-9","article-title":"Locus coeruleus neurons: cessation of activity during cataplexy","volume":"91","author":"Wu","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.smrv.2018.09.006_bib47","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.1925546","article-title":"Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla","volume":"252","author":"Siegel","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.smrv.2018.09.006_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0306-4522(02)00089-1","article-title":"Cataplexy-related neurons in the amygdala of the narcoleptic dog","volume":"112","author":"Gulyani","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.smrv.2018.09.006_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1614552114","article-title":"Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activity","volume":"114","author":"Hasegawa","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smrv.2018.09.006_bib50","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1523\/JNEUROSCI.4065-15.2017","article-title":"GABAergic neurons of the central amygdala promote cataplexy","volume":"37","author":"Mahoney","year":"2017","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.smrv.2018.09.006_bib51","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1523\/JNEUROSCI.4070-15.2017","article-title":"GABA cells in the central nucleus of the amygdala promote cataplexy","volume":"37","author":"Snow","year":"2017","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.smrv.2018.09.006_bib52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/ejn.13158","article-title":"Orexin gene transfer into the amygdala suppresses both spontaneous and emotion-induced cataplexy in orexin-knockout mice","volume":"43","author":"Liu","year":"2016","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.smrv.2018.09.006_bib53","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1523\/JNEUROSCI.0499-13.2013","article-title":"Role of the medial prefrontal cortex in cataplexy","volume":"33","author":"Oishi","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.smrv.2018.09.006_bib54","doi-asserted-by":"crossref","first-page":"9734","DOI":"10.1523\/JNEUROSCI.5632-12.2013","article-title":"Amygdala lesions reduce cataplexy in orexin knock-out mice","volume":"33","author":"Burgess","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.smrv.2018.09.006_bib55","doi-asserted-by":"crossref","first-page":"e6346","DOI":"10.1371\/journal.pone.0006346","article-title":"Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice","volume":"4","author":"Kaur","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.smrv.2018.09.006_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2016.03.001","article-title":"Locus coeruleus: from global projection system to adaptive regulation of behavior","volume":"1645","author":"Aston-Jones","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2018.09.006_bib57","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biopsych.2017.08.021","article-title":"Locus coeruleus activity mediates hyperresponsiveness in posttraumatic stress disorder","volume":"83","author":"Naegeli","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.smrv.2018.09.006_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuron.2015.11.028","article-title":"Relationships between pupil diameter and neuronal activity in the locus coeruleus, colliculi, and cingulate cortex","volume":"89","author":"Joshi","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.smrv.2018.09.006_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(01)03121-3","article-title":"Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons","volume":"922","author":"Szabo","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2018.09.006_bib60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/syn.10009","article-title":"Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus","volume":"42","author":"Szabo","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.smrv.2018.09.006_bib61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2010.11.003","article-title":"Serotonin control of sleep-wake behavior","volume":"15","author":"Monti","year":"2011","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2018.09.006_bib62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cne.20365","article-title":"Retrograde double-labeling study of common afferent projections to the dorsal raphe and the nuclear core of the locus coeruleus in the rat","volume":"481","author":"Lee","year":"2005","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.smrv.2018.09.006_bib63","doi-asserted-by":"crossref","first-page":"e4272","DOI":"10.1371\/journal.pone.0004272","article-title":"Localization of the brainstem GABAergic neurons controlling paradoxical (REM) sleep","volume":"4","author":"Sapin","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.smrv.2018.09.006_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hup.179","article-title":"Enhancement of serotoninergic function - a sometimes insufficient cause of antidepressant action","volume":"16","author":"Blier","year":"2001","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.smrv.2018.09.006_bib65","first-page":"159","article-title":"Treatment paradigms for cataplexy in narcolepsy: past, present, and future","volume":"7","author":"Swick","year":"2015","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib66","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/14656566.2017.1323877","article-title":"Pharmacological management of narcolepsy with and without cataplexy","volume":"18","author":"Kallweit","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.smrv.2018.09.006_bib67","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neuroscience.2008.10.011","article-title":"The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen","volume":"158","author":"van Nieuwenhuijzen","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.smrv.2018.09.006_bib68","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2003.12.013","article-title":"Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons","volume":"55","author":"Szabo","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.smrv.2018.09.006_bib69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.sleep.2009.08.003","article-title":"Sodium oxybate is an effective and safe treatment for narcolepsy","volume":"11","author":"Lammers","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib70","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nn.4377","article-title":"VTA dopaminergic neurons regulate ethologically relevant sleep-wake behaviors","volume":"19","author":"Eban-Rothschild","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.smrv.2018.09.006_bib71","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.neuron.2017.05.020","article-title":"Dorsal raphe dopamine neurons modulate arousal and promote wakefulness by salient stimuli","volume":"94","author":"Cho","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.smrv.2018.09.006_bib72","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nbd.2004.02.008","article-title":"The roles of midbrain and diencephalic dopamine cell groups in the regulation of cataplexy in narcoleptic Dobermans","volume":"16","author":"Okura","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.smrv.2018.09.006_bib73","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/sleep\/33.10.1295","article-title":"Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy","volume":"33","author":"Burgess","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib74","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature19325","article-title":"Locus coeruleus and dopaminergic consolidation of everyday memory","volume":"537","author":"Takeuchi","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.smrv.2018.09.006_bib75","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines","volume":"22","author":"Moron","year":"2002","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.smrv.2018.09.006_bib76","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.smrv.2018.09.006_bib77","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1126\/science.1164908","article-title":"Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI","volume":"322","author":"Minzenberg","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.smrv.2018.09.006_bib78","first-page":"19","article-title":"Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in\u00a0vitro pharmacologic study","volume":"27","author":"Gallopin","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib79","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy","volume":"54","author":"US Modafinil in Narcolepsy Multicenter Study Group","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2018.09.006_bib80","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079906X100050","article-title":"The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy","volume":"22","author":"Harsh","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.smrv.2018.09.006_bib81","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.5665\/sleep.5968","article-title":"Effect of oral JZP-110 (ADX-N05) on wakefulness and sleepiness in adults with narcolepsy: a phase 2b study","volume":"39","author":"Ruoff","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib82","doi-asserted-by":"crossref","first-page":"A250","DOI":"10.1093\/sleepj\/zsx050.674","article-title":"A\u00a0randomized, placebo-controlled, Phase 3 study of the safety and efficacy of JZP-110 for the treatment of excessive sleepiness in patients with narcolepsy","volume":"40","author":"Thorpy","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib83","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.sleep.2003.11.002","article-title":"Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy","volume":"5","author":"US Xyrem Multicenter Study Group","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib84","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/sleep\/33.9.1217","article-title":"Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss","volume":"33","author":"Walsh","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib85","doi-asserted-by":"crossref","first-page":"zsy128","DOI":"10.1093\/sleep\/zsy128","article-title":"Long-term compliance, safety, and tolerability of sodium oxybate treatment in patients with narcolepsy type 1: a post-authorization, non-interventional surveillance study","volume":"41","author":"Mayer","year":"2018","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2018.09.006_bib86","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5664\/jcsm.26368","article-title":"A\u00a0double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy","volume":"1","author":"Xyrem International Study Group","year":"2005","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib87","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2005.03.001","article-title":"Histamine excites noradrenergic neurons in locus coeruleus in rats","volume":"49","author":"Korotkova","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.smrv.2018.09.006_bib88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.106.111039","article-title":"BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: preclinical pharmacology","volume":"320","author":"Ligneau","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.smrv.2018.09.006_bib89","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-\/- mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.smrv.2018.09.006_bib90","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.smrv.2018.09.006_bib91","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1474-4422(16)30333-7","article-title":"Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Szakacs","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.smrv.2018.09.006_bib92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0404.1976.tb07621.x","article-title":"Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride","volume":"54","author":"Guilleminault","year":"1976","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.smrv.2018.09.006_bib93","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1389-9457(00)00026-5","article-title":"The use of citalopram in resistant cataplexy","volume":"1","author":"Thirumalai","year":"2000","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib94","first-page":"174","article-title":"Cataplexy treated with escitalopram--clinical experience","volume":"27","author":"Sonka","year":"2006","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.smrv.2018.09.006_bib95","first-page":"217","article-title":"Venlafaxine in the treatment of the narcoleptic syndrome","volume":"5","author":"Smith","year":"1996","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.smrv.2018.09.006_bib96","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/cap.2008.036","article-title":"Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations","volume":"19","author":"Moller","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.smrv.2018.09.006_bib97","doi-asserted-by":"crossref","first-page":"715","DOI":"10.5664\/jcsm.2848","article-title":"Status cataplecticus precipitated by abrupt withdrawal of venlafaxine","volume":"9","author":"Wang","year":"2013","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib98","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.sleep.2007.11.014","article-title":"Effective treatment of narcolepsy-cataplexy with duloxetine: a report of three cases","volume":"10","author":"Izzi","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2018.09.006_bib99","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1523\/JNEUROSCI.0080-14.2014","article-title":"GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy","volume":"34","author":"Black","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.smrv.2018.09.006_bib100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.biopsych.2016.10.012","article-title":"Trace amine-associated receptor 1 agonists as narcolepsy therapeutics","volume":"82","author":"Black","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.smrv.2018.09.006_bib101","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1021\/acs.jmedchem.5b00988","article-title":"Design and synthesis of non-peptide, selective orexin receptor 2 agonists","volume":"58","author":"Nagahara","year":"2015","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.smrv.2018.09.006_bib102","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1073\/pnas.1700499114","article-title":"Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models","volume":"114","author":"Irukayama-Tomobe","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smrv.2018.09.006_bib103","series-title":"The American Psychiatric publishing textbook of psychopharmacology","first-page":"3","article-title":"Introduction to neurotransmitters, receptors, signal transduction, and second messengers in psychiatric disorders","author":"Szabo","year":"2009"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079218300303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079218300303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:22:35Z","timestamp":1761067355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079218300303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":103,"alternative-id":["S1087079218300303"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2018.09.006","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}